Pular para o conteúdo

Interações medicamentosas

Blinatumomab + Sirolimus

Gravidade: Moderada

Blinatumomab and Sirolimus: moderate interaction.

Última atualização

Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.

O conteúdo clínico desta página está disponível apenas em inglês.

Resumo

Blinatumomab causes transient cytokine release that can suppress CYP450 enzymes, mainly in the first days of each cycle. This may transiently raise sirolimus concentrations and cause toxicity.

O que esta interação significa em palavras simples

Blinatumomab and Sirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Blinatumomab belongs to Oncology; Sirolimus belongs to Miscellaneous.

Nível de evidência: Low

Por que acontece

Cytokine-mediated transient suppression of CYP3A4 reducing sirolimus metabolism.

O que fazer

Monitor sirolimus trough levels and toxicity during the first days of each blinatumomab cycle. Adjust the sirolimus dose as needed.

O que perguntar ao farmacêutico

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Para assinantes do Pro+

Desbloqueie a página completa

Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Blinatumomab e Sirolimus, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Experimente o Pro+ grátis por 14 dias na web. Sem cartão.

Perguntas frequentes

Can I take Blinatumomab with Sirolimus?

MediHelp rates the interaction as moderate. Blinatumomab and Sirolimus can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Blinatumomab causes transient cytokine release that can suppress CYP450 enzymes, mainly in the first days of each cycle. This may transiently raise sirolimus concentrations and cause toxicity.

How serious is the interaction between Blinatumomab and Sirolimus?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor sirolimus trough levels and toxicity during the first days of each blinatumomab cycle. Adjust the sirolimus dose as needed.

What other medicines interact with Sirolimus?

MediHelp also lists interactions of Sirolimus with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Sirolimus page.

Monografias completas, posologia e verificador de interações no app MediHelp

Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.

Explorar de A a Z · Interações medicamentosas

Baixar o app Entrar